The Multiple Myeloma Channel is supported with funding from AbbVie (Platinum), Sanofi (Gold), Legend Biotech (Bronze), and through an educational grant from Alexion Pharma GmbH.
The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2017 | Cellular therapy: a key part of EBMT 2017
Nicolaus Kröger, MD, from the University Medical Center Hamburg-Eppendorf, Hamburg, Germany, speaks about how the rising field of cellular therapy has been one of the essential parts of the 2017 EBMT meeting. He highlights debates about how to avoid relapse after stem cell transplantation in hematological malignancies, as well as the rising field of cell therapy. Recorded at the 2017 annual meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Marseille, France.
